These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26743551)

  • 21. Hepatitis C: the next 25years.
    Houghton M
    Antiviral Res; 2014 Oct; 110():77-8. PubMed ID: 25043637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response letter: Just a matter of luck?
    Donato MF; Malinverno F; Monico S
    Liver Int; 2015 Jun; 35(6):1777. PubMed ID: 25676703
    [No Abstract]   [Full Text] [Related]  

  • 23. One step closer to elimination of hepatitis C in Egypt.
    Esmat G; El-Sayed MH; Hassany M; Doss W; Waked I;
    Lancet Gastroenterol Hepatol; 2018 Oct; 3(10):665. PubMed ID: 30215356
    [No Abstract]   [Full Text] [Related]  

  • 24. The oncogenic hepatitis C virus and direct-acting antivirals: economic implications for hepatocellular carcinoma in Medicaid beneficiaries with cirrhosis.
    Mantravadi S
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP180-SP184. PubMed ID: 28665676
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of liver cancer with new curative hepatitis C antivirals: Real-world challenges.
    Soriano V; Tefferi A
    Cancer; 2018 Apr; 124(8):1647-1649. PubMed ID: 29486060
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatitis C Virus.
    Kaplan DE
    Ann Intern Med; 2020 Sep; 173(5):ITC33-ITC48. PubMed ID: 32866406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response.
    Bruno S; Di Marco V; Iavarone M; Roffi L; Boccaccio V; Crosignani A; Cabibbo G; Rossi S; Calvaruso V; Aghemo A; Giacomelli L; Craxì A; Colombo M; Maisonneuve P
    Liver Int; 2017 Oct; 37(10):1526-1534. PubMed ID: 28418617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Assessment and monitoring of patients with chronic hepatitis C on antiviral therapy--state of the art in 2003].
    Simon K; Szymczak A
    Pol Arch Med Wewn; 2004 Jul; 112(1):891-8. PubMed ID: 15526854
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment for hepatitis C before and after liver transplantation].
    Ueda Y; Marusawa H
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():306-10. PubMed ID: 26845950
    [No Abstract]   [Full Text] [Related]  

  • 30. Surveillance for hepatocellular carcinoma after hepatitis C virus eradication.
    Testino G
    Minerva Med; 2022 Jun; 113(3):569-570. PubMed ID: 32166937
    [No Abstract]   [Full Text] [Related]  

  • 31. Occurrence of hepatocellular carcinoma 13 years after successful antiviral treatment for HCV infection.
    Puoti C; Lanzetta G; Scotti E
    J Gastrointestin Liver Dis; 2016 Sep; 25(3):408-9. PubMed ID: 27689211
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatitis C Virus Diagnosis and the Holy Grail.
    Applegate TL; Fajardo E; Sacks JA
    Infect Dis Clin North Am; 2018 Jun; 32(2):425-445. PubMed ID: 29778264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct-acting antivirals in hepatitis C virus-positive mantle cell lymphomas.
    Merli M; Marino D; Cencini E; Rattotti S; Fraenza C; Grossi P; Bianchi B; Mora B; Sciarra R; Finotto S; Mecacci B; Passamonti F; Visco C; Arcaini L
    Hematol Oncol; 2021 Apr; 39(2):263-266. PubMed ID: 33150988
    [No Abstract]   [Full Text] [Related]  

  • 34. ["Hepatitis C awareness, searching for it and referral for therapy"].
    Zeuzem S
    MMW Fortschr Med; 2006 Apr; 148(16):8. PubMed ID: 16688939
    [No Abstract]   [Full Text] [Related]  

  • 35. Occult hepatitis C virus infection: a new form of hepatitis C.
    Carreño V
    World J Gastroenterol; 2006 Nov; 12(43):6922-5. PubMed ID: 17109511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication.
    Motoyama H; Tamori A; Kubo S; Uchida-Kobayashi S; Takemura S; Tanaka S; Ohfuji S; Teranishi Y; Kozuka R; Kawamura E; Hagihara A; Morikawa H; Enomoto M; Murakami Y; Kawada N
    PLoS One; 2018; 13(3):e0194163. PubMed ID: 29534101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnosis, treatment, and follow-up of hepatitis C-virus related liver disease. Hungarian national consensus guideline].
    Hunyady B; Gervain J; Horváth G; Makara M; Pár A; Szalay F; Telegdy L; Tornai I
    Orv Hetil; 2014 Mar; 155 Suppl():3-24. PubMed ID: 24631886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PSG consensus statement on management of hepatitis C virus infection--2003.
    Hamid S; Umar M; Alam A; Siddiqui A; Qureshi H; Butt J;
    J Pak Med Assoc; 2004 Mar; 54(3):146-50. PubMed ID: 15129876
    [No Abstract]   [Full Text] [Related]  

  • 39. Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis.
    Ravi S; Axley P; Jones D; Kodali S; Simpson H; McGuire BM; Singal AK
    Gastroenterology; 2017 Mar; 152(4):911-912. PubMed ID: 28161225
    [No Abstract]   [Full Text] [Related]  

  • 40. PRO view: treat to prevent recurrence of HCV.
    Everson GT
    Liver Int; 2015 Jan; 35(1):5-6. PubMed ID: 25729804
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.